HERMAN BARB: Open Payments
NPI 1225117682 · TURNERSVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,967 in 255 payments from 21 companies in 2025. Trend: 2023 $2,838 · 2024 $3,551 · 2025 $3,967
Food & beverage: $3,967
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 29 | $471 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $418 |
| Vanda Pharmaceuticals Inc. | 25 | $416 |
| Teva Pharmaceuticals USA, Inc. | 30 | $348 |
| Axsome Therapeutics, Inc. | 17 | $311 |
| ABBVIE INC. | 21 | $282 |
| Alkermes, Inc. | 11 | $215 |
| E.R. Squibb & Sons, L.L.C. | 14 | $204 |
| Braeburn Inc. | 5 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $171 |
Products named: INGREZZA, CAPLYTA, FANAPT, AUSTEDO XR, Auvelity, VRAYLAR, REXULTI, COBENFY.
Industry payments across NJ — which companies pay providers there.
